Top 9 renflexis.com competitors & alternatives
[RENFLEXIS® (infliximab-abda) | Official Patient Web Site
Find information about RENFLEXIS® (infliximab-abda), including how to transition from Remicade® (infliximab) to RENFLEXIS. Talk to your doctor to see if RENFLEXIS is right for you.]
renflexis.com competitors and alternatives
Top 9 renflexis.com competitors and alternatives are ranked by similar search terms, traffic and worth.
renflexis.com's top 5 competitors are: merckconnect.com with 465 daily traffic and 233,100 estimated worth, merckhelps.com with 0 daily traffic and 38,000 estimated worth, bdipharma.com with 200 daily traffic and 7,300 estimated worth, getaid.org with 0 daily traffic and 6,900 estimated worth, biosimilarsrr.com with 0 daily traffic and 0 estimated worth.
merckconnect.com
Official Website for Health Care Professionals | MerckConnect.com
MerckConnect is a site for health care professionals to find information about Merck's listed products, as well as request samples and/or coupons.
Daily Traffic: 465
Website Worth: $ 233,100
merckhelps.com
Merck Patient Assistance Programs to Help Those in Need - Official Site
Merck Patient Assistance Programs to Help Those in Need - Official Site
Daily Traffic: 0
Website Worth: $ 38,000
getaid.org
GETAID: Groupe d'Étude Thérapeutique des Affections Inflammatoires du Tube Digestif
Leader des groupes de recherches académiques européen dans les MICI, Le GETAID a développé avec le soutien institutionnel de Pfizer, une chaine de podcast
Daily Traffic: 0
Website Worth: $ 6,900
biosimilarsrr.com
The Evolution of the Biosimilars Market | BR&R
Our coverage of biosimilar news includes education, commentary (in the form of biosimilar blogs), and updates on the marketplace.
Daily Traffic: 0
Website Worth: $ 0
biosimilarsip.com
Biosimilars Law Bulletin | Rothwell Figg | Biologics and Biosimilars Practice
Authored and edited by Rothwell Figg attorneys, Biosimilars Law Bulletin provides updates and analysis about regulatory issues, legal decisions and other news related to biologics and biosimilars under the Biologics Price Competition and Innovation Act (BPCIA).
Daily Traffic: 0
Website Worth: $ 0
remicadehcp.com
REMICADE® (infliximab) HCP Information for Healthcare Professionals
REMICADE®, a prescription biologic for treatment of gastroenterological, dermatological, & rheumatic conditions. See full Product & Safety Info, including Boxed Warnings.
Daily Traffic: 0
Website Worth: $ 0
merckaccessprogram.com
The Merck Access Program for Health Care Professionals
The Merck Access Program may help health care professionals answer questions about insurance coverage, reimbursement, and more.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like renflexis.com